POLYMEDNSEPoly Medicure Limited· PharmaceuticalsLowNeutral
Announced Thu, 25 Sept · 17:32 IST

Poly Medicure Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 25, 2025

Board & Shareholder Meetings View source PDF

POLYMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Poly Medicure held its 30th AGM on September 25, 2025, via video conferencing, chaired by Managing Director Himanshu Baid. A total of 86 members attended (4 from promoter group, 82 from public), and the Statutory and Secretarial Auditor reports had no qualifications. Ten resolutions were put to vote, including adoption of FY25 financial statements, declaration of a dividend, re-appointment of directors, and appointment of a new Whole-time Director (Pankaj Kumar Gupta). A key proposal seeks shareholder approval to raise the company's borrowing limit from ₹400 crore to ₹1,000 crore under Section 180(1)(c) of the Companies Act, 2013. The meeting concluded at 11:01 AM, with combined voting results to be announced within two working days.

Likely market impact

Shareholders should watch for the voting results, particularly the borrowing limit hike to ₹1,000 crore which signals potential expansion or capex plans. The clean audit report and proposed dividend are positive signals, while approval of the higher borrowing cap could lead to increased debt and interest costs if utilised.